The DOI matches its Crossref record.
Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion Pump
Abstract
To improve plasma glucose control, we administered insulin via the subcutaneous route in seven ambulatory patients with juvenile diabetes (12 to 17 years of age), using a portable infusion pump at a basal rate with pulse-dose increments before meals. After two to four days, the mean plasma glucose (+/- 1 S.E.) of 94 +/- 5 mg per deciliter was markedly lower than when insulin was given by conventional methods in the patients' usual dose (243 +/- 28, P less than 0.01) or in a total dose equivalent to that administered with the pump (150 +/- 15, P less than 0.01). Maximal fluctuations in plasma glucose were also 50 to 150 mg per deciliter below those observed with conventional treatment (P less than 0.001). Glycosuria was eliminated in six of seven patients during pump treatment. None of the subjects had hypoglycemia. These results demonstrate that plasma glucose can be lowered to normal in ambulatory patients with brittle juvenile diabetes using a portable, subcutaneous insulin infusion system for two to four days. The feasibility and value of the long-term application of this technic need exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 23
- 10.1056/NEJM197604292941811 · DOI · Paper page
- 10.1056/NEJM197705052961812 · DOI
- 10.1056/NEJM197705262962111 · DOI
- Service, 1970, Diabetes, 19, 644, 10.2337/diab.19.9.644 · DOI · Paper page
- Molnar, 1972, Mayo Clin Proc, 47, 709
- 10.1055/s-0028-1093738 · DOI
- Albisser, 1974, Diabetes, 23, 397, 10.2337/diab.23.5.397 · DOI · Paper page
- 10.1055/s-0028-1093841 · DOI
- 10.1007/BF01219712 · DOI
- 10.2337/diabetes.26.6.571 · DOI
- 10.1007/BF01220633 · DOI
- Hepp, 1977, Horm Metab Res [Suppl], 7, 72
- Service, 1978, J Lab Clin Med, 91, 480
- 10.1136/bmj.1.6107.204 · DOI · Paper page
- 10.1016/S0140-6736(57)92595-3 · DOI · Paper page
- 10.1007/BF01218495 · DOI · Paper page
- 10.1111/j.0954-6820.1965.tb01810.x · DOI · Paper page
- Snedecor GW, Cochran WG: Statistical Methods. Sixth edition. Ames, Iowa State University Press, 1967
- Shima, 1977, Diabetes, 26, 717, 10.2337/diab.26.8.717 · DOI
- 10.1210/jcem-47-5-1160 · DOI
- 10.1172/JCI106989 · DOI · Paper page
- 10.1007/BF00425888 · DOI · Paper page
- 10.7326/0003-4819-79-6-812 · DOI
Cited by
Artificial Pancreas: Past, Present, Future
Cobelli, C., Renard, E., & Kovatchev, B. (2011) · Diabetes · doi:10.2337/db11-0654 · Cited by 600
Misso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
White, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Amiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309
Self-citationTanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296
Insulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
Coming of age: the artificial pancreas for type 1 diabetes
Thabit, H., & Hovorka, R. (2016) · Diabetologia · doi:10.1007/s00125-016-4022-4 · Cited by 223
Importance of Raised Growth Hormone Levels in Mediating the Metabolic Derangements of Diabetes
Press, M., Tamborlane, W. V., & Sherwin, R. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101302 · Cited by 198
Self-citationISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
The artificial pancreas: current status and future prospects in the management of diabetes
Peyser, T., Dassau, E., Breton, M., & Skyler, J. S. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12431 · Cited by 169
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
Schmid, V., Hohberg, C., Borchert, M., Forst, T., & Pfützner, A. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400429 · Cited by 97
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes
Kovatchev, B., Tamborlane, W. V., Cefalu, W. T., & Cobelli, C. (2016) · Diabetes Care · doi:10.2337/dc16-0824 · Cited by 95
Self-citationA Century of Diabetes Technology: Signals, Models, and Artificial Pancreas Control
Kovatchev, B. (2019) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.04.008 · Cited by 80
Raskin, P., Holcombe, J. H., Tamborlane, W. V., Malone, J. I., Strowig, S., Ahern, J. A., & Lavent, F. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00168-4 · Cited by 71
Self-citationAlemzadeh, R., Ellis, J. N., Holzum, M. K., Parton, E. A., & Wyatt, D. T. (2004) · Pediatrics · doi:10.1542/peds.114.1.e91 · Cited by 63
Choudhary, P., & Amiel, S. A. (2018) · Diabetologia · doi:10.1007/s00125-018-4566-6 · Cited by 52
Gerich, J. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90584-2 · Cited by 50
Advancing Our Understanding of the Glucose System via Modeling: A Perspective
Cobelli, C., Dalla Man, C., Pedersen, M. G., Bertoldo, A., & Toffolo, G. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2014.2310514 · Cited by 46
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Moving toward the ideal insulin for insulin pumps
Cengiz, E., Bode, B., Van Name, M., & Tamborlane, W. V. (2016) · Expert Review of Medical Devices · doi:10.1586/17434440.2016.1109442 · Cited by 38
Self-citationFeldberg, D., Dicker, D., Samuel, N., Peleg, D., Karp, M., Goldman, J. A., & Goldman, J. A. (1988) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016348809004231 · Cited by 33
Continuous subcutaneous insulin infusion: practical issues
Saboo, B., & Talaviya, P. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.104055 · Cited by 32
“Continuous subcutaneous insulin infusion (CSII) was first introduced as a management strategy for both adult[1] and pediatric[2] patients with type 1 diabetes mellitus (T1DM) in the late 1970s.”
BackgroundClinical approaches to treat impaired awareness of hypoglycaemia
Farrell, C. M., & McCrimmon, R. J. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211000248 · Cited by 31
The Clinical Outcomes after Total Pancreatectomy
Suzuki, S., Kajiyama, H., Takemura, A., Shimazaki, J., Nishida, K., & Shimoda, M. (2017) · Digestive Surgery · doi:10.1159/000449234 · Cited by 30
SERVICE, F. J., RIZZA, R. A., HALL, L. D., WESTLAND, R. E., O’BRIEN, P. C., CLEMENS, A. H., HAYMOND, M. W., & GERICH, J. E. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-5-931 · Cited by 25
Metadata
- Authors
- Tamborlane, W. V., Sherwin, R. S., Genel, M., & Felig, P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1979-03-15
- Volume
- 300
- Issue
- 11
- Pages
- 573-578
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2327215697
- Cited by
- 411
- References
- 0
- FWCI
- 31.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
